The Implant Lab Limited xbrl








The Implant Lab Limited


Company Registration Number
10003389


Report of the Directors and
Abridged Unaudited Financial Statements


Period of accounts

Start date 01/03/2024

End date 28/02/2025






















							Page 1

The Implant Lab Limited

Contents of the Financial Statements
for the Period Ended 28 February 2025


							Page
Company Information							3

Abridged Balance Sheet							4 - 5

Notes to the Financial Statements							6 - 7
































							Page 2

The Implant Lab Limited
Company Information
for the Period Ended 28 February 2025

Directors	A Davies

Company secretary	M Davies

Registered office	52 Ardwick Green South
	Manchester
	M13 9XF

Company Registration Number	10003389






























		Page 3

The Implant Lab Limited
Balance Sheet
for the Period Ended 28 February 2025
Company registration number 10003389
		2025	2,024
	Notes	£	£
Fixed assets
Tangible fixed assets		2,011	2,681
		_______	_______
Total fixed assets		2,011	2,681
Current assets
Debtors		500,000	545,723
Cash at bank and in hand		353,896	195,657
		_______	_______
Total current assets/(liabilities)		853,896	741,380
Creditors
Creditors - amounts falling
due within one year		264,936	308,696
		_______	_______
Net current assets		588,960	432,684
		_______	_______
Total assets less current liabilities		590,971	435,365
		_______	_______
Net assets/(liabilities)		590,971	435,365
Capital and reserves
Called up share capital	2	100	100
Profit and loss account		590,871	435,265
		______	______
Total shareholders funds		590,971	435,365













			Page 4

The Implant Lab Limited

Balance Sheet

for the Period Ended 28 February 2025

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The option not to file the profit and loss account has been taken.

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The members have agreed to the preparation of abridged accounts.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The financial statements were approved by the Board of Directors on

2025-11-18

SIGNED ON BEHALF OF THE BOARD BY

Name

A Davies

The notes form part of these financial statements

Average number of employees during period

Page 5

The Implant Lab Limited

Notes to the Financial Statements

for the Period Ended 28 February 2025

1. Accounting policies

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with the small companies regime.

Tangible fixed assets Depreciation

Depreciation is provided, after taking account of any grants receivable, at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

25% reducing balance

Page 6

The Implant Lab Limited
Notes to the Financial Statements
for the Period Ended 28 February 2025
2. Share capital		2025	2,024
Authorised type	Par value	£	£
Ordinary	1	100	100
		___	___
Total		100	100
Allotted, called up and paid		£	£
Ordinary		100	100
		___	___
Total		100	100



















			Page 7